查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血液透析機和腹膜透析市場規模：依產品（設備、血液管線、濃縮液（鹼性）、導管、透析設備、水處理、服務）、模式（CAPD、夜間）、使用者（醫院、居家醫療）、地區- 世界預計到 2029 年
市場調查報告書
商品編碼
1468740

血液透析機和腹膜透析市場規模：依產品（設備、血液管線、濃縮液（鹼性）、導管、透析設備、水處理、服務）、模式（CAPD、夜間）、使用者（醫院、居家醫療）、地區- 世界預計到 2029 年

Hemodialysis and Peritoneal Dialysis Market Size by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) & Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 305 Pages | 訂單完成後即時交付

價格
簡介目錄

全球血液透析機和腹膜透析市場規模預計將從 2024 年的 920 億美元增至 2029 年的 1,262 億美元，預測期內複合年成長率為 6.5%。

全球老年人口的快速增加和腎臟相關疾病的顯著增加預計將推動血液透析機和腹膜透析市場的需求。此外，家庭血液透析機使用率的逐步增加預計也將推動市場成長。透析治療技術和政府政策的進步、醫療保健基礎設施的投資以及改善透析服務可及性的努力也有望支持市場成長。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
單元 金額（美元）
部分 產品和服務、適應症、最終用戶、地區
目標區域 亞太地區、北美、歐洲、中東和非洲、拉丁美洲

按產品/服務分類，血液透析機服務業在預測期內將以最高複合年成長率成長：

按產品和服務分類，血液透析機服務業預計在預測期內將呈現高成長率。這是由於末期腎病患者對血液透析機治療的需求不斷增加，以及血液透析機服務供應商的成長。

按最終用戶分類，末期腎病 (ESRD) 領域佔最大比例：

從最終用戶來看，ESRD 細分市場預計將在預測期內佔據最大的市場佔有率。糖尿病、高血壓和慢性腎臟病等慢性病的增加增加了患有末期腎病（ESRD）風險的患者數量。開發中國家醫療保健服務的改善、對腎臟疾病的認知的提高以及在 ESRD 管理中更多地使用血液透析機療法也支持了該行業的成長。

按地區分類，北美所佔佔有率最大：

北美是最大的區域市場，而亞太地區預計在預測期內將以最高的複合年成長率成長。

北美佔比最大，可能是由於慢性腎臟病的疾病負擔較高以及需要血液透析機和腹膜透析治療的患者數量眾多。北美地區眾多透析服務供應商的存在、提供血液透析機、腹膜透析和家庭透析治療服務的透析中心數量的增加以及該地區有利的報銷政策預計將推動北美市場的成長。

該報告調查了全球血液透析機和腹膜透析市場，並提供了市場概況、市場影響因素和市場機會分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測以及各種其他資訊。總結了按細分市場和地區、競爭狀況、主要企業概況等進行的詳細分析。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 監管狀況
  • 報銷分析
  • 生態系/市場地圖
  • 價值鏈分析
  • 供應鏈分析
  • 技術分析
  • 專利分析
  • 價格分析
  • 貿易分析
  • 波特五力分析
  • 主要會議及活動
  • 主要相關利益者和採購標準
  • 投資金籌措場景

第6章血液透析機市場：依產品及服務分類

  • 血液透析機服務
    • 中心血液透析機服務
    • 居家血液透析機服務
  • 血液透析機產品
    • 裝置
    • 消耗品和用品
  • 血液透析機市場：依方法分類
    • 常規長期血液透析機
    • 短期透析
    • 夜間血液透析機
  • 水處理系統市場：按類型
    • 中央水消毒系統
    • 可攜式水消毒系統

第7章腹膜透析市場：依產品及服務分類

  • 產品
    • 濃縮液/透析液
    • 裝置
    • 導管
    • 傳輸集
    • 其他
  • 服務
  • 腹膜透析市場：依方式分類
    • 連續性攜帶式腹膜透析
    • 自動腹膜透析

第8章血液透析機及腹膜透析市場：依疾病分類

  • 晚期腎臟疾病
  • 急性腎損傷
  • 其他

第9章血液透析機和腹膜透析市場：依最終用戶分類

  • 醫院
  • 獨立透析中心
  • 居家醫療
  • 其他

第10章血液透析機及腹膜透析市場：依地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第11章競爭格局

  • 主要策略
  • 收益分析
  • 市場佔有率分析
  • 企業評價矩陣：主要企業
  • 公司評估矩陣：Start-Ups/中小企業
  • 評價及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章 公司簡介

  • 主要企業
    • FRESENIUS MEDICAL CARE AG
    • BAXTER
    • DAVITA INC.
    • NIKKISO CO., LTD.
    • B. BRAUN SE
    • MEDTRONIC
    • ASAHI KASEI CORPORATION
    • TERUMO CORPORATION
    • TORAY MEDICAL CO., LTD.
    • NIPRO CORPORATION
    • DIAVERUM AB
    • DIALIFE SA
    • ISOPURE CORP.
    • ROCKWELL MEDICAL, INC.
    • BECTON, DICKINSON AND COMPANY
  • 其他公司
    • JMS CO. LTD.
    • ALLMED MEDICAL PRODUCTS CO., LTD.
    • ATLANTIC BIOMEDICAL
    • ANGIODYNAMICS
    • AMECATH
    • COOK
    • MEDICAL COMPONENTS INC.
    • POLYMEDICURE
    • XYLEM
    • OUTSET MEDICAL, INC.

第13章附錄

簡介目錄
Product Code: MD 2157

The global hemodialysis and peritoneal dialysis market is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period. The rapid growth in the geriatric population globally and the significant rise in the patients' kidney-related diseases are expected to boost the demand for the Hemodialysis and peritoneal dialysis market. Moreover, gradual rise in utilization of home hemodialysis is likely to support the market growth. Advancements in dialysis treatment technology and government policies, investments in healthcare infrastructure, and initiatives to enhance the accessibility of dialysis services are anticipated to fuel the market growth.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct and Services, Disease Indication, End user, and Region
Regions coveredAsia Pacific, North America, Europe, Middle East and Africa, and LATAM

"The hemodialysis services segment of hemodialysis products and services market to grow with the highest CAGR during the forecast period."

Based on the hemodialysis products and services market, the hemodialysis services segment is anticipated to grow at a significant rate during the forecast period. This is attributed to the rising demand for hemodialysis treatment among patients with end stage renal disease and the growth of hemodialysis service providers, focusing on extending the hemodialysis services offered through the collaboration with many dialysis centers to meet the increasing demand and improve patient outcomes.

"The End Stage Renal Disease (ESRD) segment to capture the largest market share of hemodialysis and peritoneal dialysis market."

Based on disease indication the Hemodialysis and peritoneal dialysis market are segmented into acute kidney Injury (AKI), End end-stage renal Disease (ESRD) and other disease indications including electrolyte imbalance, fluid overload, and poisoning. The ESRD segment held the largest market share during the forecast period. The rising incidence of chronic conditions such as diabetes, hypertension and the growing prevalence of chronic kidney disease are leading to the larger pool of patients at a risk of developing ESRD. Improved access to healthcare services in developing countries and the growing awareness about the kidney disease and the increasing utilization of Hemodialysis treatment for ESRD management are likely to support the growth of the segment.

"North America accounted for the largest share of the hemodialysis and peritoneal dialysis market by region."

The global hemodialysis and peritoneal dialysis market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for hemodialysis and peritoneal dialysis products and services, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

The largest share of North America can be attributed to the high disease burden of chronic kidney disease contributing to a larger pool of patients requiring hemodialysis and peritoneal dialysis treatment. The presence of numerous dialysis services providers, increasing number of dialysis centers in North America offering hemodialysis, peritoneal dialysis, and home dialysis services, and favorable reimbursement policy in the region is likely to promote the growth of hemodialysis and peritoneal dialysis market in North America.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-25%, Tier 2-30%, and Tier 3- 45%
  • By Designation: C-level-26%, Director-level-30%, and Others-44%
  • By Region: North America-40%, Europe-31%, Asia Pacific-20%, Latin America-6%, and the Middle East & Africa-3%

The major players operating in the hemodialysis and peritoneal dialysis market market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Braun Melsungen AG (Germany), Nipro Corporation (Japan), DaVita Inc. (US), Nikkiso Co., Ltd. (Japan), Asahi Kasei Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany).

Research Coverage

This report studies the hemodialysis and peritoneal dialysis market based on hemodialysis and peritoneal dialysis products and services, disease indication, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Analysis of Key divers (increasing number of ESRD patients, technological advancement in hemodialysis and peritoneal dialysis equipment, growing prevalence of diabetes and hypertension ), restraints (high cost of hemodialysis treatment, reimbursement concerns in emerging countries, complication associated with dialysis procedure), Opportunities (emerging markets, gradual shift towards home hemodialysis ), Challenge (Product recall)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hemodialysis and peritoneal dialysis market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the hemodialysis and peritoneal dialysis market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the hemodialysis and peritoneal dialysis market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS
  • 1.4 STUDY SCOPE
    • 1.4.1 MARKETS COVERED
    • FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SEGMENTS COVERED
    • 1.4.2 REGIONS COVERED
    • FIGURE 2 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGIONS COVERED
    • 1.4.3 YEARS CONSIDERED
    • 1.4.4 CURRENCY CONSIDERED
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 RESEARCH DESIGN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
    • 2.1.1 SECONDARY DATA
    • FIGURE 4 INDICATIVE LIST OF SECONDARY SOURCES
    • 2.1.2 PRIMARY DATA
    • FIGURE 5 LIST OF KEY PRIMARY SOURCES
    • FIGURE 6 KEY INDUSTRY INSIGHTS
    • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 USAGE-BASED MARKET ESTIMATION
    • FIGURE 8 ESTIMATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES, BY COUNTRY/REGION
    • FIGURE 9 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT UTILIZATION METHODOLOGY
    • FIGURE 10 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES MARKET, BY REVENUE MAPPING METHODOLOGY
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 IMPACT OF ECONOMIC RECESSION ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
    • TABLE 2 GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 12 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
    • FIGURE 13 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
    • FIGURE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET

4 PREMIUM INSIGHTS

  • 4.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW
    • FIGURE 16 RISING PREVALENCE OF END-STAGE RENAL DISEASE AND GROWING AWARENESS ABOUT DIALYSIS TREATMENT TO DRIVE MARKET
  • 4.2 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
    • FIGURE 17 HEMODIALYSIS CONSUMABLES & SUPPLIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 HEMODIALYSIS MARKET, BY MODALITY, 2024 VS. 2029 (USD BILLION)
    • FIGURE 18 CONVENTIONAL LONG-TERM HEMODIALYSIS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
  • 4.4 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE AND COUNTRY (2023)
    • FIGURE 19 JAPAN AND PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.5 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of chronic kidney diseases
    • FIGURE 22 CANADA: NUMBER OF TOTAL INCIDENTS OF END-STAGE RENAL DISEASE PATIENTS, BY AGE GROUP (2022)
    • TABLE 3 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2012 VS. 2050
      • 5.2.1.2 Growing prevalence of diabetes and hypertension
    • FIGURE 23 US: REPORTED CAUSES OF END-STAGE RENAL DISEASES, 2023
      • 5.2.1.3 Technological advancements and increased investment in R&D
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risks and complications of dialysis treatments
      • 5.2.2.2 High procedural cost of dialysis
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing growth opportunities in emerging economies
    • FIGURE 24 INCIDENCE OF TREATED END-STAGE RENAL DISEASE PATIENTS, 2021
      • 5.2.3.2 Rising number of dialysis centers
      • 5.2.3.3 Growing preference for home hemodialysis
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing number of product recalls
      • 5.2.4.2 Shortage of skilled nephrologists and lack of training programs in low-income countries
  • 5.3 REGULATORY LANDSCAPE
    • 5.3.1 REGULATORY ANALYSIS
      • 5.3.1.1 North America
        • 5.3.1.1.1 US
        • 5.3.1.1.2 Canada
      • 5.3.1.2 Europe
      • 5.3.1.3 Asia Pacific
        • 5.3.1.3.1 India
        • 5.3.1.3.2 China
        • 5.3.1.3.3 Japan
        • 5.3.1.3.4 South Korea
      • 5.3.1.4 Latin America
        • 5.3.1.4.1 Brazil
        • 5.3.1.4.2 Mexico
      • 5.3.1.5 Middle East
      • 5.3.1.6 Africa
    • 5.3.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4 REIMBURSEMENT ANALYSIS
    • TABLE 9 MEDICAL REIMBURSEMENT CODES FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES
    • 5.4.1 NORTH AMERICA
    • 5.4.2 EUROPE
      • 5.4.2.1 Germany
      • 5.4.2.2 France
      • 5.4.2.3 UK
    • 5.4.3 ASIA PACIFIC
      • 5.4.3.1 India
      • 5.4.3.2 China
      • 5.4.3.3 Japan
      • 5.4.3.4 Pacific Region
      • 5.4.3.5 Other Asia Pacific Countries
  • 5.5 ECOSYSTEM/MARKET MAP
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 25 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Portable hemodialysis
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 Biocompatible dialysis membrane
      • 5.8.2.2 Connected health and remote sensors
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 Wearable artificial kidney
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
    • FIGURE 27 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2013-MARCH 2024)
    • 5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 28 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEMODIALYSIS MACHINE PATENTS (JANUARY 2013-MARCH 2024)
    • FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PERITONEAL DIALYSIS CYCLER PATENTS (JANUARY 2013-MARCH 2024)
    • FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEMODIALYSIS DIALYSATE PATENTS (JANUARY 2013-MARCH 2024)
  • 5.10 PRICING ANALYSIS
    • TABLE 10 AVERAGE PRICE OF HEMODIALYSIS AND PERITONEAL DIALYSIS SYSTEMS AND CONSUMABLES IN 2022, BY COUNTRY (USD)
    • TABLE 11 AVERAGE SELLING PRICE OF HEMODIALYSIS & PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER (USD)
  • 5.11 TRADE ANALYSIS
    • TABLE 12 IMPORT DATA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES (HS CODE 901890), BY COUNTRY, 2019-2023 (USD THOUSAND)
    • TABLE 13 EXPORT DATA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES (HS CODE 901890), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY CONFERENCES & EVENTS, 2024-2025
    • TABLE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, 2024-2025
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
    • TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
    • 5.14.2 KEY BUYING CRITERIA
    • FIGURE 32 KEY BUYING CRITERIA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
    • TABLE 17 BUYING CRITERIA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
  • 5.15 INVESTMENT & FUNDING SCENARIO
    • FIGURE 33 INVESTMENT AND FUNDING SCENARIO FOR HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET PLAYERS

6 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 18 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD BILLION)
  • 6.2 HEMODIALYSIS SERVICES
    • TABLE 19 HEMODIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 20 HEMODIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY REGION, 2022-2029 (USD BILLION)
    • 6.2.1 IN-CENTER HEMODIALYSIS SERVICES
      • 6.2.1.1 Growing geriatric population and increasing government healthcare expenditure to drive segment
    • TABLE 21 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD BILLION)
    • 6.2.2 HOME HEMODIALYSIS SERVICES
      • 6.2.2.1 Poor reimbursement scenario and high treatment costs to limit market growth
    • TABLE 22 HOME HEMODIALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD BILLION)
  • 6.3 HEMODIALYSIS PRODUCTS
    • TABLE 23 HEMODIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 24 HEMODIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY REGION, 2022-2029 (USD BILLION)
    • 6.3.1 HEMODIALYSIS MACHINES
    • TABLE 25 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 26 HEMODIALYSIS MACHINES MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.1.1 Center-use hemodialysis machines
        • 6.3.1.1.1 Rising number of renal care centers to aid segment growth
    • TABLE 27 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.1.2 Home-use hemodialysis machines
        • 6.3.1.2.1 Lesser hospital stays and better clinical outcomes to propel segment growth
    • TABLE 28 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2022-2029 (USD BILLION)
    • 6.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES
    • TABLE 29 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 30 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.2.1 Dialyzers
    • TABLE 31 DIALYZERS MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.1.1 Dialyzers market, by material
    • TABLE 32 DIALYZERS MARKET, BY MATERIAL, 2022-2029 (USD BILLION)
          • 6.3.2.1.1.1 Synthetic dialyzers
    • TABLE 33 SYNTHETIC DIALYZERS MARKET, BY REGION, 2022-2029 (USD BILLION)
          • 6.3.2.1.1.2 Cellulose-based dialyzers
    • TABLE 34 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.1.2 Dialyzers market, by flux
    • TABLE 35 DIALYZERS MARKET, BY FLUX, 2022-2029 (USD BILLION)
          • 6.3.2.1.2.1 High-flux dialyzers
    • TABLE 36 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2022-2029 (USD BILLION)
          • 6.3.2.1.2.2 Low-flux dialyzers
    • TABLE 37 LOW-FLUX DIALYZERS MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.2.2 Bloodlines
        • 6.3.2.2.1 High pricing and reduced rate of reuse to limit market
    • TABLE 38 BLOODLINES MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.2.3 Concentrates/Dialysates
    • TABLE 39 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 40 CONCENTRATES/DIALYSATES MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.3.1 Alkaline concentrates
          • 6.3.2.3.1.1 Growing consumption before dialysis to boost segment growth
    • TABLE 41 ALKALINE CONCENTRATES MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.3.2 Acidic concentrates
          • 6.3.2.3.2.1 Increased number of side effects to limit segment growth
    • TABLE 42 ACIDIC CONCENTRATES MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.2.4 Access products
    • TABLE 43 ACCESS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 44 ACCESS PRODUCTS MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.4.1 AV fistula needles
          • 6.3.2.4.1.1 Better blood flow and lower infection risk to aid segment growth
    • TABLE 45 AV FISTULA NEEDLES MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.4.2 AV grafts
          • 6.3.2.4.2.1 Increased number of patients requiring long-term dialysis to support segment growth
    • TABLE 46 AV GRAFTS MARKET, BY REGION, 2022-2029 (USD BILLION)
        • 6.3.2.4.3 Central venous catheters
          • 6.3.2.4.3.1 Increased use in temporary vascular access for short-term dialysis to boost segment growth
    • TABLE 47 CENTRAL VENOUS CATHETERS MARKET, BY REGION, 2022-2029 (USD BILLION)
      • 6.3.2.5 Other hemodialysis consumables & supplies
    • TABLE 48 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2022-2029 (USD BILLION)
  • 6.4 HEMODIALYSIS MARKET, BY MODALITY
    • TABLE 49 HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 6.4.1 CONVENTIONAL LONG-TERM HEMODIALYSIS
      • 6.4.1.1 Technological advancements and rising number of dialysis centers to drive segment
    • TABLE 50 HEMODIALYSIS MARKET FOR CONVENTIONAL LONG-TERM HEMODIALYSIS, BY REGION, 2022-2029 (USD BILLION)
    • 6.4.2 SHORT DAILY HEMODIALYSIS
      • 6.4.2.1 Improved blood pressure control and better calcium-phosphorus balance to augment segment growth
    • TABLE 51 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY REGION, 2022-2029 (USD BILLION)
    • 6.4.3 NOCTURNAL HEMODIALYSIS
      • 6.4.3.1 Lower procedure costs to aid segment growth
    • TABLE 52 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY REGION, 2022-2029 (USD BILLION)
  • 6.5 WATER TREATMENT SYSTEMS MARKET, BY TYPE
    • TABLE 53 WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 54 WATER TREATMENT SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.5.1 CENTRAL WATER DISINFECTION SYSTEMS
      • 6.5.1.1 Cost effectiveness and easy maintenance to drive market
    • TABLE 55 WATER TREATMENT SYSTEMS MARKET FOR CENTRAL WATER DISINFECTION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
    • 6.5.2 PORTABLE WATER DISINFECTION SYSTEMS
      • 6.5.2.1 User-friendly operations and improved microbiological purity to support segment growth
    • TABLE 56 WATER TREATMENT SYSTEMS MARKET FOR PORTABLE WATER DISINFECTION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)

7 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
    • TABLE 57 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD BILLION)
  • 7.2 PERITONEAL DIALYSIS PRODUCTS
    • TABLE 58 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 59 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY REGION, 2022-2029 (USD BILLION)
    • 7.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
      • 7.2.1.1 High demand for concentrates to boost segment growth
    • TABLE 60 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2022-2029 (USD BILLION)
    • 7.2.2 PERITONEAL DIALYSIS MACHINES
      • 7.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
    • TABLE 61 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2022-2029 (USD BILLION)
    • 7.2.3 PERITONEAL DIALYSIS CATHETERS
      • 7.2.3.1 Favorable reimbursement policies to support market growth
    • TABLE 62 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2022-2029 (USD BILLION)
    • 7.2.4 PERITONEAL DIALYSIS TRANSFER SETS
      • 7.2.4.1 Increasing number of patients in emerging economies to aid market growth
    • TABLE 63 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2022-2029 (USD BILLION)
    • 7.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS
    • TABLE 64 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2022-2029 (USD BILLION)
  • 7.3 PERITONEAL DIALYSIS SERVICES
    • 7.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
    • TABLE 65 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY REGION, 2022-2029 (USD BILLION)
  • 7.4 PERITONEAL DIALYSIS MARKET, BY MODALITY
    • TABLE 66 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 7.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
      • 7.4.1.1 Superior clearance of high-molecular-weight substances to drive market
    • TABLE 67 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2022-2029 (USD BILLION)
    • 7.4.2 AUTOMATED PERITONEAL DIALYSIS
      • 7.4.2.1 Risk of rapid decline in residual renal functions to limit adoption
    • TABLE 68 PERITONEAL DIALYSIS MARKET FOR AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2022-2029 (USD BILLION)

8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION

  • 8.1 INTRODUCTION
    • TABLE 69 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION, 2022-2029 (USD BILLION)
  • 8.2 END-STAGE RENAL DISEASE
    • 8.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
    • TABLE 70 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY REGION, 2022-2029 (USD BILLION)
  • 8.3 ACUTE KIDNEY INJURY
    • 8.3.1 INCREASE IN NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH
    • TABLE 71 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY REGION, 2022-2029 (USD BILLION)
  • 8.4 OTHER DISEASES
    • TABLE 72 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD BILLION)

9 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 73 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2022-2029 (USD BILLION)
  • 9.2 HOSPITALS
    • 9.2.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
    • TABLE 74 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD BILLION)
  • 9.3 INDEPENDENT DIALYSIS CENTERS
    • 9.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH
    • TABLE 75 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS MARKET, BY REGION, 2022-2029 (USD BILLION)
  • 9.4 HOME CARE SETTINGS
    • 9.4.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
    • TABLE 76 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD BILLION)
  • 9.5 OTHER END USERS
    • TABLE 77 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD BILLION)

10 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 78 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2022-2029 (USD BILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 34 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
    • TABLE 79 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
    • TABLE 80 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 81 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 82 NORTH AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 83 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2022-2029 (USD BILLION)
    • TABLE 84 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2022-2029 (USD BILLION)
    • TABLE 85 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 86 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 87 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 88 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 89 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 90 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 91 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.2.2 US
      • 10.2.2.1 US to account for largest market share during study period
    • TABLE 92 US: MACROECONOMIC INDICATORS
    • TABLE 93 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 94 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 95 US: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 96 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 97 US: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 98 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 99 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 100 US: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Shortage of dialysis facilities and increased treatment cost to limit market
    • TABLE 101 CANADA: MACROECONOMIC INDICATORS
    • TABLE 102 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 103 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 104 CANADA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 105 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 106 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 107 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 108 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 109 CANADA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
  • 10.3 EUROPE
    • 10.3.1 EUROPE: RECESSION IMPACT
    • TABLE 110 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
    • TABLE 111 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 112 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 113 EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 114 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 115 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 116 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 117 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 118 EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Rising number of end-stage renal disease patients to boost market growth
    • TABLE 119 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 120 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 121 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 122 GERMANY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 123 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 124 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 125 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 126 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 127 GERMANY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increased number of new dialysis centers and technological advancements to support market growth
    • TABLE 128 UK: MACROECONOMIC INDICATORS
    • TABLE 129 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 130 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 131 UK: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 132 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 133 UK: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 134 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 135 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 136 UK: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 High cost of dialysis treatment and variation in reimbursement policies to limit market growth
    • TABLE 137 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 138 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 139 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 140 FRANCE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 141 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 142 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 143 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 144 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 145 FRANCE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Increasing research activities and growing patient population with acute renal failure to augment market growth
    • TABLE 146 ITALY: MACROECONOMIC INDICATORS
    • TABLE 147 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 148 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 149 ITALY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 150 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 151 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 152 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 153 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 154 ITALY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Favorable reimbursement scenario to boost market growth
    • TABLE 155 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 156 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 157 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 158 SPAIN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 159 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 160 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 161 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 162 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 163 SPAIN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 164 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 165 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 166 REST OF EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 167 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 168 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 169 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 170 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 35 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
    • TABLE 171 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
    • TABLE 172 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 173 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 174 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 175 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 176 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 177 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 178 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 179 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 High prevalence of end-stage renal disease and large geriatric population to support market growth
    • TABLE 180 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 181 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 182 JAPAN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 183 JAPAN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 184 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 185 JAPAN: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 186 JAPAN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 187 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 188 JAPAN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 Increasing prevalence of diabetes and hypertension to drive market
    • TABLE 189 CHINA: MACROECONOMIC INDICATORS
    • TABLE 190 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 191 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 192 CHINA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 193 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 194 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 195 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 196 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 197 CHINA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Favorable government initiatives and high prevalence of kidney disease to fuel market growth
    • TABLE 198 INDIA: MACROECONOMIC INDICATORS
    • TABLE 199 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 200 INDIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 201 INDIA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 202 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 203 INDIA: HEMODIALYSIS MARKET, BY MODALITY 2022-2029 (USD BILLION)
    • TABLE 204 INDIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 205 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 206 INDIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Increasing government initiatives about renal care to support market growth
    • TABLE 207 AUSTRALIA: MACROECONOMIC INDICATORS
    • TABLE 208 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 209 AUSTRALIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 210 AUSTRALIA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 211 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 212 AUSTRALIA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 213 AUSTRALIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 214 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 215 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Growing geriatric population with chronic kidney disease to propel market growth
    • TABLE 216 SOUTH KOREA: MACROECONOMIC INDICATORS
    • TABLE 217 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 218 SOUTH KOREA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 219 SOUTH KOREA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 220 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 221 SOUTH KOREA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 222 SOUTH KOREA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 223 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 224 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 225 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 226 REST OF ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 227 REST OF ASIA PACIFIC: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 228 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2022-2029 (USD BILLION)
    • TABLE 229 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 230 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 231 REST OF ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 232 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 233 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 234 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
    • TABLE 235 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 236 LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 237 LATIN AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 238 LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2022-2029 (USD BILLION)
    • TABLE 239 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 240 LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 241 LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 242 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 243 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to account for largest share of Latin American market during forecast period
    • TABLE 244 BRAZIL: MACROECONOMIC INDICATORS
    • TABLE 245 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 246 BRAZIL: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 247 BRAZIL: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 248 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 249 BRAZIL: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 250 BRAZIL: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 251 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 252 BRAZIL: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing patient population and growing middle class population to boost market growth
    • TABLE 253 MEXICO: MACROECONOMIC INDICATORS
    • TABLE 254 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 255 MEXICO: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 256 MEXICO: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 257 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 258 MEXICO: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 259 MEXICO: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 260 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 261 MEXICO: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 262 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 263 REST OF LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 264 REST OF LATIN AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 265 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 266 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 267 REST OF LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 268 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 269 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 270 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 271 MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 272 MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 273 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 274 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 275 MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 276 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Higher disposable income and increased government healthcare expenditure to propel market growth
    • TABLE 278 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 279 GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 280 GCC COUNTRIES: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 281 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 282 GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 283 GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 284 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 285 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • 10.6.3 REST OF MIDDLE EAST & AFRICA
    • TABLE 286 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 287 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 288 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 289 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 290 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)
    • TABLE 291 REST OF MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 292 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022-2029 (USD BILLION)
    • TABLE 293 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022-2029 (USD BILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY STRATEGIES/RIGHT-TO-WIN
    • FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: STRATEGIES ADOPTED
  • 11.3 REVENUE ANALYSIS
    • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS (2019-2023)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
    • TABLE 294 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 PERVASIVE PLAYERS
    • 11.5.3 EMERGING LEADERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS
    • TABLE 295 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OVERALL FOOTPRINT
      • 11.5.5.1 Regional footprint
    • TABLE 296 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGIONAL FOOTPRINT
      • 11.5.5.2 Product & service footprint
    • TABLE 297 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT & SERVICE FOOTPRINT
      • 11.5.5.3 Disease indication footprint
    • TABLE 298 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DISEASE INDICATION FOOTPRINT
      • 11.5.5.4 End user footprint
    • TABLE 299 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: END USER FOOTPRINT
  • 11.6 COMPETITIVE EVALUATION MATRIX: START-UPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
    • 11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES
    • TABLE 300 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 301 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.7 VALUATION & FINANCIAL METRICS
    • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • 11.8 BRAND/PRODUCT COMPARISON
    • TABLE 302 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARISON, BY PRODUCT
    • FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCT
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 303 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MARCH 2024
    • 11.9.2 DEALS
    • TABLE 304 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEALS, JANUARY 2021-MARCH 2024
    • 11.9.3 EXPANSIONS
    • TABLE 305 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 11.9.4 OTHER DEVELOPMENTS
    • TABLE 306 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2024

12 COMPANY PROFILES

  • (Business overview, Products/Solutions/Services offered, Recent developments & MnM View)**
  • 12.1 KEY PLAYERS
    • 12.1.1 FRESENIUS MEDICAL CARE AG
    • TABLE 307 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
    • FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2022)
    • TABLE 308 FRESENIUS MEDICAL CARE AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 309 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES
    • TABLE 310 FRESENIUS MEDICAL CARE AG: DEALS
    • 12.1.2 BAXTER
    • TABLE 311 BAXTER: COMPANY OVERVIEW
    • FIGURE 44 BAXTER: COMPANY SNAPSHOT (2023)
    • TABLE 312 BAXTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 313 BAXTER: DEALS
    • 12.1.3 DAVITA INC.
    • TABLE 314 DAVITA INC.: COMPANY OVERVIEW
    • FIGURE 45 DAVITA INC.: COMPANY SNAPSHOT (2023)
    • TABLE 315 DAVITA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 316 DAVITA INC.: DEALS
    • TABLE 317 DAVITA INC.: EXPANSIONS
    • 12.1.4 NIKKISO CO., LTD.
    • TABLE 318 NIKKISO CO., LTD.: COMPANY OVERVIEW
    • FIGURE 46 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2022)
    • TABLE 319 NIKKISO CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 320 NIKKISO CO., LTD.: DEALS
    • 12.1.5 B. BRAUN SE
    • TABLE 321 B. BRAUN SE: COMPANY OVERVIEW
    • FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2022)
    • TABLE 322 B. BRAUN SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 323 B. BRAUN SE: PRODUCT LAUNCHES
    • TABLE 324 B. BRAUN SE: EXPANSIONS
    • 12.1.6 MEDTRONIC
    • TABLE 325 MEDTRONIC: COMPANY OVERVIEW
    • FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2023)
    • TABLE 326 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 327 MEDTRONIC: DEALS
    • 12.1.7 ASAHI KASEI CORPORATION
    • TABLE 328 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
    • FIGURE 49 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 329 ASAHI KASEI CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 330 ASAHI KASEI CORPORATION: DEALS
    • 12.1.8 TERUMO CORPORATION
    • TABLE 331 TERUMO CORPORATION: COMPANY OVERVIEW
    • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 332 TERUMO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 333 TERUMO CORPORATION: DEALS
    • TABLE 334 TERUMO CORPORATION: OTHER DEVELOPMENTS
    • 12.1.9 TORAY MEDICAL CO., LTD.
    • TABLE 335 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW
    • FIGURE 51 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT (2022)
    • TABLE 336 TORAY MEDICAL CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.10 NIPRO CORPORATION
    • TABLE 337 NIPRO CORPORATION: COMPANY OVERVIEW
    • FIGURE 52 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 338 NIPRO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 339 NIPRO CORPORATION: DEALS
    • 12.1.11 DIAVERUM AB
    • TABLE 340 DIAVERUM AB: COMPANY OVERVIEW
    • TABLE 341 DIAVERUM AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.12 DIALIFE SA
    • TABLE 342 DIALIFE SA: COMPANY OVERVIEW
    • TABLE 343 DIALIFE SA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.13 ISOPURE CORP.
    • TABLE 344 ISOPURE CORP.: COMPANY OVERVIEW
    • TABLE 345 ISOPURE CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.14 ROCKWELL MEDICAL, INC.
    • TABLE 346 ROCKWELL MEDICAL, INC.: COMPANY OVERVIEW
    • FIGURE 53 ROCKWELL MEDICAL, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 347 ROCKWELL MEDICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 348 ROCKWELL MEDICAL, INC.: DEALS
    • 12.1.15 BECTON, DICKINSON AND COMPANY
    • TABLE 349 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 54 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
    • TABLE 350 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 351 BECTON, DICKINSON AND COMPANY: EXPANSIONS
  • *Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 JMS CO. LTD.
    • TABLE 352 JMS CO. LTD.: COMPANY OVERVIEW
    • 12.2.2 ALLMED MEDICAL PRODUCTS CO., LTD.
    • TABLE 353 ALLMED MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW
    • 12.2.3 ATLANTIC BIOMEDICAL
    • TABLE 354 ATLANTIC BIOMEDICAL: COMPANY OVERVIEW
    • 12.2.4 ANGIODYNAMICS
    • TABLE 355 ANGIODYNAMICS: COMPANY OVERVIEW
    • 12.2.5 AMECATH
    • TABLE 356 AMECATH: COMPANY OVERVIEW
    • 12.2.6 COOK
    • TABLE 357 COOK: COMPANY OVERVIEW
    • 12.2.7 MEDICAL COMPONENTS INC.
    • TABLE 358 MEDICAL COMPONENTS INC.: COMPANY OVERVIEW
    • 12.2.8 POLYMEDICURE
    • TABLE 359 POLYMEDICURE: COMPANY OVERVIEW
    • 12.2.9 XYLEM
    • TABLE 360 XYLEM: COMPANY OVERVIEW
    • 12.2.10 OUTSET MEDICAL, INC.
    • TABLE 361 OUTSET MEDICAL, INC.: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.2 CUSTOMIZATION OPTIONS
  • 13.3 RELATED REPORTS
  • 13.4 AUTHOR DETAILS